Timothys Ernst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Platinum Investment Management Ltd. lessened its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 52.9% during the second quarter, Holdings Channel reports. The firm owned 8,636 shares of the medical research company’s stock after selling 9,706 shares during the quarter. Platinum Investment Management Ltd.’s holdings in Bio-Rad Laboratories were worth $3,274,000 […]

Thompson Siegel & Walmsley LLC boosted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 44.8% during the second quarter, Holdings Channel.com reports. The firm owned 294,164 shares of the medical research company’s stock after buying an additional 91,013 shares during the quarter. Bio-Rad Laboratories makes up approximately 1.8% of Thompson […]

Envestnet Asset Management Inc. lifted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 5.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 114,996 shares of the medical research company’s stock after purchasing an additional 5,761 shares during […]

Impax Asset Management Group plc boosted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 74.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,879 shares of the medical research company’s stock after acquiring […]

StockNews.com downgraded shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a buy rating to a hold rating in a research report sent to investors on Monday morning. A number of other research firms also recently weighed in on BIO. Royal Bank of Canada lifted their price target on Bio-Rad Laboratories from $522.00 to $524.00 […]